Pfizer Announces Positive Top-Line Results for JAK Inhibitor in Ankylosing Spondylitis Trial
Ankylosing Spondylitis (AS) is a chronic, inflammatory disease that causes enthesitis or inflammation where the tendons, ligaments, and bones meet. This debilitating condition affects approximately 1% of the US population, …
Read More